VJHemOnc is committed to improving our service to you

Myeloma 2017 | The biases of using bone marrow biopsies for multiple myeloma

VJHemOnc is committed to improving our service to you

Jens Lohr

A full understanding of the methods available for diagnosis, prognosis and stratification are required in order to choose the optimal method depending on the cirumstances. In this video, recorded at the Myeloma 2017 meeting in Edinburgh, UK, Jens Lohr, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the selection and site bias of using bone marrow biopsies for multiple myeloma. Dr Lohr also questions how representative liquid biopsies are.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter